로딩 중…
지수 로딩 중…
ImmunityBio, Inc.
IBRX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.36+5.29%
2026-06-18
Price Chart
ImmunityBio, Inc.+159.15%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $7.71B |
| Revenue | $141M |
| Net Income | $-855M |
| Total Assets | $647M |
| Net Assets | $-870M |
| Value | |
| P/S | 54.68x |
| FCF Yield | -3.88% |
| Profitability | |
| Op. Margin | -185.41% |
| Revenue Growth | 167.64% |
| Financial Health | |
| Total Debt | $1.12B |
| FCF | $-299M |
| Cash | $205M |
| Current Ratio | 6.67x |
| Performance | |
| 1Y Return | 159.15% |
| 1M Return | -5.15% |
| From 52W High | -40.79% |
| 1Y MDD | -42.44% |
| Trading | |
| Volume | 12,947,324 shares |
| Trading Value | $94M |
| Per Share | |
| EPS | $-0.36 |